NasdaqCM - Delayed Quote USD
Medicus Pharma Ltd. (MDCX)
2.5500
-1.0850
(-29.85%)
At close: May 30 at 4:00:02 PM EDT
2.5300
-0.02
(-0.78%)
After hours: May 30 at 7:32:56 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.25 | -0.22 | -1 | -0.77 |
| Low Estimate | -0.39 | -0.31 | -1.46 | -1.12 |
| High Estimate | -0.12 | -0.12 | -0.55 | -0.43 |
| Year Ago EPS | -- | -- | -1.16 | -1 |
Revenue Estimate
| Currency in CAD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 4 |
| Avg. Estimate | -- | -- | -- | 49.44k |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 197.74k |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | 0.00% | 0.00% |
Earnings History
| Currency in USD | 12/31/2024 | 3/31/2025 |
|---|---|---|
| EPS Est. | -0.31 | -0.22 |
| EPS Actual | -0.18 | -0.42 |
| Difference | 0.14 | -0.21 |
| Surprise % | 42.86% | -95.35% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.25 | -0.22 | -1 | -0.77 |
| 7 Days Ago | -0.18 | -0.16 | -0.71 | -0.64 |
| 30 Days Ago | -0.18 | -0.16 | -0.71 | -0.63 |
| 60 Days Ago | 0 | 0 | -1.53 | -0.95 |
| 90 Days Ago | 0 | 0 | -1.53 | -0.95 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 1 | 1 | 1 | 2 |
| Down Last 30 Days | 1 | 1 | 1 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MDCX | -- | -- | 13.36% | 22.89% |
| S&P 500 | 13.08% | 2.48% | 7.55% | 13.96% |
Upgrades & Downgrades
| Maintains | D. Boral Capital: Buy to Buy | 5/29/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 5/22/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 5/12/2025 |
| Maintains | Maxim Group: Buy to Buy | 5/8/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 4/28/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 4/21/2025 |
Related Tickers
SCLX Scilex Holding Company
5.12
-9.38%
SNY Sanofi
49.37
-5.69%
AZN AstraZeneca PLC
72.83
+2.77%
AMRN Amarin Corporation plc
11.59
-0.77%
AMGN Amgen Inc.
288.18
+1.64%
OGN Organon & Co.
9.22
-3.35%
NVS Novartis AG
115.76
+2.82%
NONOF Novo Nordisk A/S
71.14
+2.80%
MRK Merck & Co., Inc.
76.84
+0.58%
BMY Bristol-Myers Squibb Company
48.28
+0.90%